NO315837B1 - Sur blanding for humant konsum omfattende kreatin, samt fremgangsmåte for levering av en kreatinholdig blanding - Google Patents

Sur blanding for humant konsum omfattende kreatin, samt fremgangsmåte for levering av en kreatinholdig blanding Download PDF

Info

Publication number: NO315837B1
Authority: NO; Norway
Prior art keywords: creatine; mixture; mixture according; drink; acidic
Prior art date: 1996-05-31

Application number

NO19985532A

Other languages

English (en)

Norwegian (no)

Other versions

NO985532D0 (no

NO985532L (no

Inventor

Alan Norman Howard

Roger Charles Harris

Original Assignee

Howard Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-31

Filing date

1998-11-27

Publication date

2003-11-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309414&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO315837(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-11-27 Application filed by Howard Foundation filed Critical Howard Foundation

1998-11-27 Publication of NO985532D0 publication Critical patent/NO985532D0/no

1999-01-26 Publication of NO985532L publication Critical patent/NO985532L/no

2003-11-03 Publication of NO315837B1 publication Critical patent/NO315837B1/no

Links

CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title claims abstract description 178
229960003624 creatine Drugs 0.000 title claims abstract description 89
239000006046 creatine Substances 0.000 title claims abstract description 89
239000000203 mixture Substances 0.000 title claims abstract description 73
230000002378 acidificating effect Effects 0.000 title claims abstract description 17
238000000034 method Methods 0.000 title claims description 10
239000000843 powder Substances 0.000 claims abstract description 17
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
235000013618 yogurt Nutrition 0.000 claims description 18
239000003792 electrolyte Substances 0.000 claims description 11
239000007788 liquid Substances 0.000 claims description 9
RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims description 8
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 7
150000001720 carbohydrates Chemical class 0.000 claims description 7
235000014633 carbohydrates Nutrition 0.000 claims description 7
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
239000011575 calcium Substances 0.000 claims description 6
229910052791 calcium Inorganic materials 0.000 claims description 6
239000011591 potassium Substances 0.000 claims description 6
229910052700 potassium Inorganic materials 0.000 claims description 6
239000011734 sodium Substances 0.000 claims description 6
229910052708 sodium Inorganic materials 0.000 claims description 6
229940088594 vitamin Drugs 0.000 claims description 6
229930003231 vitamin Natural products 0.000 claims description 6
235000013343 vitamin Nutrition 0.000 claims description 6
239000011782 vitamin Substances 0.000 claims description 6
239000007864 aqueous solution Substances 0.000 claims description 5
239000003086 colorant Substances 0.000 claims description 5
239000008122 artificial sweetener Substances 0.000 claims description 4
235000021311 artificial sweeteners Nutrition 0.000 claims description 4
239000000872 buffer Substances 0.000 claims description 4
229940120503 dihydroxyacetone Drugs 0.000 claims description 4
239000000796 flavoring agent Substances 0.000 claims description 4
150000002632 lipids Chemical class 0.000 claims description 4
235000001014 amino acid Nutrition 0.000 claims description 3
150000001413 amino acids Chemical class 0.000 claims description 3
239000003963 antioxidant agent Substances 0.000 claims description 3
235000006708 antioxidants Nutrition 0.000 claims description 3
235000013355 food flavoring agent Nutrition 0.000 claims description 3
239000003755 preservative agent Substances 0.000 claims description 3
239000003381 stabilizer Substances 0.000 claims description 3
239000011573 trace mineral Substances 0.000 claims description 3
235000013619 trace mineral Nutrition 0.000 claims description 3
239000002253 acid Substances 0.000 claims 1
159000000003 magnesium salts Chemical class 0.000 claims 1
238000003860 storage Methods 0.000 abstract description 10
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 34
239000000243 solution Substances 0.000 description 20
229940109239 creatinine Drugs 0.000 description 17
238000009472 formulation Methods 0.000 description 12
238000002474 experimental method Methods 0.000 description 8
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
239000012153 distilled water Substances 0.000 description 6
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
210000001124 body fluid Anatomy 0.000 description 5
239000010839 body fluid Substances 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
239000011777 magnesium Substances 0.000 description 5
229910052749 magnesium Inorganic materials 0.000 description 5
210000003205 muscle Anatomy 0.000 description 5
230000009469 supplementation Effects 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
108010011485 Aspartame Proteins 0.000 description 4
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 4
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000000605 aspartame Substances 0.000 description 4
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
235000010357 aspartame Nutrition 0.000 description 4
229960003438 aspartame Drugs 0.000 description 4
239000000306 component Substances 0.000 description 4
235000005911 diet Nutrition 0.000 description 4
230000037213 diet Effects 0.000 description 4
239000012895 dilution Substances 0.000 description 4
238000010790 dilution Methods 0.000 description 4
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
238000001556 precipitation Methods 0.000 description 4
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
230000004580 weight loss Effects 0.000 description 4
MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
229940077731 carbohydrate nutrients Drugs 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
235000020971 citrus fruits Nutrition 0.000 description 3
229960004826 creatine monohydrate Drugs 0.000 description 3
229910052500 inorganic mineral Inorganic materials 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000011707 mineral Substances 0.000 description 3
235000010755 mineral Nutrition 0.000 description 3
239000011574 phosphorus Substances 0.000 description 3
229910052698 phosphorus Inorganic materials 0.000 description 3
239000004033 plastic Substances 0.000 description 3
210000002027 skeletal muscle Anatomy 0.000 description 3
SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 2
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
241000207199 Citrus Species 0.000 description 2
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
235000021102 Greek yogurt Nutrition 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
229930003779 Vitamin B12 Natural products 0.000 description 2
229930003268 Vitamin C Natural products 0.000 description 2
229930003427 Vitamin E Natural products 0.000 description 2
239000003929 acidic solution Substances 0.000 description 2
235000013361 beverage Nutrition 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
229960000673 dextrose monohydrate Drugs 0.000 description 2
238000010586 diagram Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
229940064302 folacin Drugs 0.000 description 2
235000019152 folic acid Nutrition 0.000 description 2
239000011724 folic acid Substances 0.000 description 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
235000001497 healthy food Nutrition 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
230000002045 lasting effect Effects 0.000 description 2
235000004213 low-fat Nutrition 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
229960003512 nicotinic acid Drugs 0.000 description 2
235000001968 nicotinic acid Nutrition 0.000 description 2
239000011664 nicotinic acid Substances 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
229940055726 pantothenic acid Drugs 0.000 description 2
235000019161 pantothenic acid Nutrition 0.000 description 2
239000011713 pantothenic acid Substances 0.000 description 2
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
229960002477 riboflavin Drugs 0.000 description 2
235000019192 riboflavin Nutrition 0.000 description 2
239000002151 riboflavin Substances 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
239000013589 supplement Substances 0.000 description 2
235000019157 thiamine Nutrition 0.000 description 2
239000011721 thiamine Substances 0.000 description 2
235000019163 vitamin B12 Nutrition 0.000 description 2
239000011715 vitamin B12 Substances 0.000 description 2
235000019158 vitamin B6 Nutrition 0.000 description 2
239000011726 vitamin B6 Substances 0.000 description 2
235000019154 vitamin C Nutrition 0.000 description 2
239000011718 vitamin C Substances 0.000 description 2
235000019165 vitamin E Nutrition 0.000 description 2
229940046009 vitamin E Drugs 0.000 description 2
239000011709 vitamin E Substances 0.000 description 2
229940011671 vitamin b6 Drugs 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
244000248349 Citrus limon Species 0.000 description 1
235000005979 Citrus limon Nutrition 0.000 description 1
240000000560 Citrus x paradisi Species 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
206010033307 Overweight Diseases 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
239000000619 acesulfame-K Substances 0.000 description 1
239000002535 acidifier Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
235000013734 beta-carotene Nutrition 0.000 description 1
239000011648 beta-carotene Substances 0.000 description 1
TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
229960002747 betacarotene Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000004040 coloring Methods 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
229940109275 cyclamate Drugs 0.000 description 1
HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000037149 energy metabolism Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002270 ergogenic effect Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
239000011888 foil Substances 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005428 food component Substances 0.000 description 1
229960001031 glucose Drugs 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
235000015122 lemonade Nutrition 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
229940077676 low-energy diet formulations for treatment of obesity Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
235000019629 palatability Nutrition 0.000 description 1
210000003254 palate Anatomy 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
229950007002 phosphocreatine Drugs 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000037081 physical activity Effects 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
JKVUQLWTIZFTMF-UHFFFAOYSA-M potassium;2-oxopropanoate Chemical compound [K+].CC(=O)C([O-])=O JKVUQLWTIZFTMF-UHFFFAOYSA-M 0.000 description 1
239000000047 product Substances 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
235000021057 semi-liquid food Nutrition 0.000 description 1
230000009192 sprinting Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
230000009182 swimming Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000002699 waste material Substances 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1
OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Nutrition Science (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Mycology (AREA)
Botany (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Enzymes And Modification Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Non-Alcoholic Beverages (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Confectionery (AREA)
Detergent Compositions (AREA)

NO19985532A 1996-05-31 1998-11-27 Sur blanding for humant konsum omfattende kreatin, samt fremgangsmåte for levering av en kreatinholdig blanding NO315837B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9611356.8A GB9611356D0 (en)	1996-05-31	1996-05-31	Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
PCT/GB1997/001476 WO1997045026A1 (en)	1996-05-31	1997-05-30	Improvements in or relating to compositions containing creatine
ZA9710788A ZA9710788B (en)	1996-05-31	1997-12-01	Compositions containing creatine.

Publications (3)

Publication Number	Publication Date
NO985532D0 NO985532D0 (no)	1998-11-27
NO985532L NO985532L (no)	1999-01-26
NO315837B1 true NO315837B1 (no)	2003-11-03

Family

ID=26309414

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19985532A NO315837B1 (no)	1996-05-31	1998-11-27	Sur blanding for humant konsum omfattende kreatin, samt fremgangsmåte for levering av en kreatinholdig blanding

Country Status (17)

Country	Link
US (1)	US5968544A (de)
EP (1)	EP0912110B1 (de)
JP (1)	JP3485576B2 (de)
CN (2)	CN1220583A (de)
AT (1)	ATE229280T1 (de)
AU (1)	AU733474B2 (de)
BR (1)	BR9709418B1 (de)
CA (1)	CA2253580C (de)
DE (1)	DE69717815T2 (de)
EA (1)	EA001388B1 (de)
ES (1)	ES2188945T3 (de)
GB (2)	GB9611356D0 (de)
NO (1)	NO315837B1 (de)
NZ (1)	NZ332408A (de)
PL (1)	PL330205A1 (de)
WO (1)	WO1997045026A1 (de)
ZA (1)	ZA9710788B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274161B1 (en) *	1996-05-31	2001-08-14	The Howard Foundation	Compositions containing creatine in suspension
US8128955B2 (en)	1996-05-31	2012-03-06	The Original Creatine Patent Company	Food compositions containing creatine
US6168802B1 (en) *	1996-05-31	2001-01-02	The Howard Foundation	Compositions containing creatine and aloe vera extract
US7150880B2 (en) *	1996-05-31	2006-12-19	The Original Creatine Patent Co. Ltd.	Compositions containing creatine and creatinine and a methyl xanthine
US6524611B2 (en)	1996-05-31	2003-02-25	The Howard Foundation	Compositions containing creatine and creatinine
US5965596A (en)	1997-08-12	1999-10-12	Harris; Roger	Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en)	1996-08-12	2009-03-17	Natural Alternatives International	Methods and compositions for increasing the anaerobic working capacity in tissues
EP0971911A1 (de) *	1997-02-26	2000-01-19	SKW Trostberg Aktiengesellschaft	Kreatin-ascorbate und verfahren zu deren herstellung
DE19707694A1 (de) *	1997-02-26	1998-08-27	Sueddeutsche Kalkstickstoff	Kreatin-ascorbate und Verfahren zu deren Herstellung
WO1999000122A1 (de) *	1997-06-25	1999-01-07	Ipr-Institute For Pharmaceutical Research Ag	Verfahren zur reduktion des körpergewichtes
DE19729786A1 (de) *	1997-07-11	1999-01-14	Sueddeutsche Kalkstickstoff	Verfahren zur Herstellung von Calciumpyruvaten
TW404833B (en) *	1997-07-11	2000-09-11	Sueddeutsche Kalkstickstoff	A method of producing calcium pyruvates
US6159942A (en) *	1998-06-19	2000-12-12	Bioenergy, Inc.	Compositions for increasing energy in vivo
EP1051914A1 (de) *	1999-05-08	2000-11-15	DSM Fine Chemicals Austria GmbH	Verwendung von Kreatin als Futterzusatz
CA2373806A1 (en) *	1999-07-06	2001-01-11	Societe Des Produits Nestle S.A.	Isotonic juice drink for children
JP2001131065A (ja) *	1999-11-05	2001-05-15	Meiji Seika Kaisha Ltd	体脂肪減少促進剤及び体脂肪減少促進用食品組成物
GB0015617D0 (en) *	2000-06-26	2000-08-16	Vectura Ltd	Improved preparations for dermal delivery of active substances
US6399661B1 (en)	2000-06-26	2002-06-04	Jeffrey M. Golini	Oral creatine supplement and method for making same
US6897228B2 (en) *	2000-07-07	2005-05-24	Medicure International Inc.	Pyridoxine and pyridoxal analogues: new uses
WO2002069740A1 (en) *	2001-03-02	2002-09-12	The Howard Foundation	Compositions containing creatine and creatinine
DE10133198A1 (de) *	2001-07-07	2003-01-23	Beiersdorf Ag	Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10136077A1 (de) *	2001-07-25	2003-02-13	Beiersdorf Ag	Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
DE10136076A1 (de) *	2001-07-25	2003-02-13	Beiersdorf Ag	Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen
US20040013732A1 (en) *	2001-09-25	2004-01-22	Michael Farber	Starch-based delivery system for creatine
DE10159244A1 (de) *	2001-12-03	2003-06-18	Degussa Bioactives Deutschland	Feste und stabile Kreatin/Citronensäure-Zusammensetzung(en) und Kohlenhydrat(e) bzw. deren Hydrate enthaltende Formulierung, Verfahren zu ihrer Herstellung und deren Verwendung
US7067150B2 (en)	2002-04-16	2006-06-27	Scepter Holdings, Inc.	Delivery systems for functional ingredients
US20030211133A1 (en) *	2002-05-10	2003-11-13	Special Ops Nutrition, L.L.C.	Ingestible composition for enhancing athletic performance
DE10301632A1 (de) *	2003-01-17	2004-07-29	Beiersdorf Ag	Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten
US6982098B1 (en) *	2003-05-30	2006-01-03	Fun Unlimited Inc.	Nutritional weight loss agent and method
US20050100637A1 (en) *	2003-11-12	2005-05-12	Robert Murray	Carbohydrate and electrolyte replacement composition
DE10355711A1 (de) *	2003-11-26	2005-06-16	Beiersdorf Ag	Kosmetische und dermatologische Emulsionen, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen, einer Ionenstärke von mindestens 50 mmol/l
US20060045906A1 (en) *	2004-08-25	2006-03-02	Gardiner Paul T	Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
US8283327B2 (en) *	2005-03-19	2012-10-09	Kneller Bruce W	Palatinose for enhancing dietary supplement and pharmaceutical delivery
JP5336180B2 (ja)	2005-05-23	2013-11-06	ナチュラルオータナティブスインターナショナル	β−アラニンの徐放のための組成物及び方法
JP2007209231A (ja) *	2006-02-08	2007-08-23	Japan Organo Co Ltd	クレアチン含有食品組成物
JP2009527504A (ja) *	2006-02-23	2009-07-30	イオメディックススリープインターナショナルエスアールエル	良質な睡眠の誘導および維持のための組成物および方法
AU2007249811A1 (en) *	2006-05-11	2007-11-22	Avicena Group, Inc.	Creatine-ligand compounds and methods of use thereof
SI2222300T1 (sl)	2007-12-13	2014-11-28	Vanda Pharmaceuticals Inc.	Postopek in sestavek za zdravljenje stanja, posredovanega z receptorjem serotonina
BRPI0820993A2 (pt)	2007-12-13	2017-05-09	Vanda Pharmaceuticals Inc	método e composição para tratar uma condição mediada por alfa adrenoceptor
DE102007062288A1 (de)	2007-12-21	2009-06-25	Alzchem Trostberg Gmbh	Kreatin-Zubereitung und Verfahren zu deren Herstellung
US8435590B2 (en)	2008-11-24	2013-05-07	Stokely-Van Camp, Inc.	Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
WO2010074591A1 (ru)	2008-12-24	2010-07-01	Закрытое Акционерное Общество "Beptekc"	Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
US8703719B1 (en)	2009-05-18	2014-04-22	Bio-Engineered Supplements And Nutrition, Inc.	Method and composition for improved muscle performance
RU2463800C2 (ru) *	2009-09-23	2012-10-20	Закрытое акционерное общество "Академия-Т"	Сухой специализированный белково-углеводный продукт для питания спортсменов
AU2010343129B2 (en)	2009-12-29	2013-05-16	Hill's Pet Nutrition, Inc.	Compositions including pyruvate for companion animals and methods of use thereof
JP6584777B2 (ja) *	2015-01-16	2019-10-02	太陽化学株式会社	水分電解質補給飲料用粉末組成物
US11617737B2 (en) *	2016-12-15	2023-04-04	Société des Produits Nestlé S.A.	Compositions and methods that modulate vitamin D and bone mineral content in a companion animal
US12568991B2 (en)	2017-10-18	2026-03-10	Glanbia Dairy Nutrition Limited	Method for increasing the solubility and stability of organic compositions
BR112020007883A2 (pt) *	2017-10-18	2020-11-03	Glanbia Nutritionals (Ireland) Ltd.	composições de ácido orgânico nitrogenoso estáveis em prateleira
US11246846B2 (en)	2017-10-23	2022-02-15	Michael S. Tempesta	Trisodium citrate compositions having enhanced uptake across digestive mucosa
US11154499B2 (en)	2018-03-27	2021-10-26	Thermolife International, Llc	Creatine and/or creatinine compositions and related methods
US20220287346A1 (en) *	2019-08-23	2022-09-15	The Coca-Cola Company	Stable creatine beverages

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL155719B (nl) *	1967-01-20	1978-02-15	Unilever Nv	Werkwijze ter bereiding van smaakstofmengsels met een vleessmaak.
NL8100815A (nl) *	1981-02-19	1982-09-16	Unilever Nv	Werkwijze ter bereiding van 4-hydroxy-5-methyl-2,3-dihydrofuran-3-on, alsmede werkwijze voor het wijzigen van de organoleptische eigenschappen van levensmiddelen en de aldus verkregen levensmiddelen.
JPS5925663A (ja) *	1982-08-02	1984-02-09	Ajinomoto Co Inc	ビ−フフレ−バ−調味料の製造法
US4647453A (en) *	1984-10-18	1987-03-03	Peritain, Ltd.	Treatment for tissue degenerative inflammatory disease
US4772591A (en) *	1985-09-25	1988-09-20	Peritain, Ltd.	Method for accelerated wound healing
GB9215746D0 (en) *	1992-07-24	1992-09-09	Hultman Eric	A method of increasing creatine supply depot
US5397786A (en) *	1993-01-08	1995-03-14	Simone; Charles B.	Rehydration drink
AU5890394A (en) *	1993-02-03	1994-08-29	Steven Andrew Jennings	Blends of glycine derivatives and sugars
JP3213666B2 (ja) *	1994-02-28	2001-10-02	治彦末岡	クレアチン飲料の製造方法
IT1271687B (it) *	1994-08-04	1997-06-04	Flamma Spa	Sali organici idrosolubili della creatina
AU4151996A (en) *	1994-11-08	1996-05-31	Avicena Group, Inc.	Use of creatine or creatine analogs for the treatment of diseases of the nervous system
JP3581727B2 (ja) *	1994-11-11	2004-10-27	株式会社日立製作所	ディスクアレイコントローラ及びディスクアレイ装置
JP3595373B2 (ja) *	1995-02-20	2004-12-02	治彦末岡	クレアチン飲料
IT1275434B (it) *	1995-05-19	1997-08-07	Farmila Farma Milano	Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

1996
- 1996-05-31 GB GBGB9611356.8A patent/GB9611356D0/en active Pending
1997
- 1997-05-30 CA CA002253580A patent/CA2253580C/en not_active Expired - Fee Related
- 1997-05-30 EA EA199801076A patent/EA001388B1/ru not_active IP Right Cessation
- 1997-05-30 JP JP54187197A patent/JP3485576B2/ja not_active Expired - Fee Related
- 1997-05-30 PL PL97330205A patent/PL330205A1/xx unknown
- 1997-05-30 NZ NZ332408A patent/NZ332408A/xx not_active IP Right Cessation
- 1997-05-30 EP EP97924142A patent/EP0912110B1/de not_active Expired - Lifetime
- 1997-05-30 GB GB9711041A patent/GB2313544B/en not_active Expired - Fee Related
- 1997-05-30 AU AU29709/97A patent/AU733474B2/en not_active Ceased
- 1997-05-30 US US08/866,517 patent/US5968544A/en not_active Expired - Lifetime
- 1997-05-30 BR BRPI9709418-8A patent/BR9709418B1/pt not_active IP Right Cessation
- 1997-05-30 WO PCT/GB1997/001476 patent/WO1997045026A1/en not_active Ceased
- 1997-05-30 ES ES97924142T patent/ES2188945T3/es not_active Expired - Lifetime
- 1997-05-30 CN CN97195137A patent/CN1220583A/zh active Pending
- 1997-05-30 DE DE69717815T patent/DE69717815T2/de not_active Expired - Lifetime
- 1997-05-30 AT AT97924142T patent/ATE229280T1/de active
- 1997-12-01 ZA ZA9710788A patent/ZA9710788B/xx unknown
1998
- 1998-11-27 NO NO19985532A patent/NO315837B1/no not_active IP Right Cessation
2001
- 2001-09-20 CN CN01133189A patent/CN1364430A/zh active Pending

Also Published As

Publication number	Publication date
AU733474B2 (en)	2001-05-17
JP2000511054A (ja)	2000-08-29
GB2313544A (en)	1997-12-03
CN1364430A (zh)	2002-08-21
GB9711041D0 (en)	1997-07-23
CA2253580C (en)	2006-10-03
CN1220583A (zh)	1999-06-23
CA2253580A1 (en)	1997-12-04
US5968544A (en)	1999-10-19
PL330205A1 (en)	1999-04-26
AU2970997A (en)	1998-01-05
GB2313544B (en)	2000-01-12
EA199801076A1 (ru)	1999-04-29
DE69717815T2 (de)	2003-11-20
BR9709418B1 (pt)	2011-03-09
BR9709418A (pt)	2000-01-11
ZA9710788B (en)	1998-08-26
JP3485576B2 (ja)	2004-01-13
DE69717815D1 (de)	2003-01-23
NO985532D0 (no)	1998-11-27
ES2188945T3 (es)	2003-07-01
NO985532L (no)	1999-01-26
GB9611356D0 (en)	1996-08-07
WO1997045026A1 (en)	1997-12-04
EP0912110B1 (de)	2002-12-11
HK1019694A1 (en)	2000-02-25
NZ332408A (en)	1999-08-30
EP0912110A1 (de)	1999-05-06
ATE229280T1 (de)	2002-12-15
EA001388B1 (ru)	2001-02-26

Legal Events

Date	Code	Title	Description
2014-12-22	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO315837B1 (no)	2003-11-03	Sur blanding for humant konsum omfattende kreatin, samt fremgangsmåte for levering av en kreatinholdig blanding
US9521859B2 (en)	2016-12-20	Substantially clear nutritional liquids comprising calcium HMB and soluble protein
EP1217904B1 (de)	2005-09-07	Mit einem calcium magnesium lactat-citrat komplex angereicherte getränke und andere flüssige lebensmittel
US4740380A (en)	1988-04-26	Calcium fortified acid beverages
US20110177176A1 (en)	2011-07-21	Gel-Based Compositions and Methods of Making Same
CA2514804A1 (en)	2004-09-02	Compositions containing creatine, creatinine and a methyl xanthine
CN102283294A (zh)	2011-12-21	一种含乳清蛋白的运动饮料及其制备方法
US6013290A (en)	2000-01-11	Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
CA2373806A1 (en)	2001-01-11	Isotonic juice drink for children
EP1399035B1 (de)	2004-10-20	Isotonisches energiegetränk und verfahren zu seiner herstellung
US20030148016A1 (en)	2003-08-07	Energy fitness water
US20060246200A1 (en)	2006-11-02	Hydroxyapatite in aqueous solution for bone health
JPH02119761A (ja)	1990-05-07	乳酸カルシウム含有飲料及び固形製剤
JP6714984B2 (ja)	2020-07-01	クエン酸由来の異味が低減された容器詰めクエン酸高含有酸性飲料
MXPA98009764A (en)	1999-09-01	Improvements in, or related to, compositions containing creat
US20230217964A1 (en)	2023-07-13	Protein Beverage Composition
HK1019694B (en)	2003-05-02	Improvements in or relating to compositions containing creatine
US20240382505A1 (en)	2024-11-21	Food product
CZ163295A3 (cs)	1997-01-15	Doplněk výživy obohacený glukózotoleraněním faktorem